Joseph Wright - 26 Feb 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
PRESIDENT, INTERNATIONAL
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
26 Feb 2022
Net transactions value
-$126,288
Form type
4
Filing time
01 Mar 2022, 19:18:56 UTC
Previous filing
17 Sep 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +6,630 +54% $0.000000 18,973 26 Feb 2022 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability $126,288 -1,942 -10% $65.03 17,031 28 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +8,094 $0.000000 8,094 26 Feb 2022 Common Stock 8,094 $65.03 Direct F2
holding MMSI Non-qualified stock options (right to buy) 9,681 26 Feb 2022 Common Stock 9,681 $56.25 Direct F3
holding MMSI Non-qualified stock options (right to buy) 20,000 26 Feb 2022 Common Stock 20,000 $16.05 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25,000 26 Feb 2022 Common Stock 25,000 $28.20 Direct F5
holding MMSI Non-qualified stock options (right to buy) 25,000 26 Feb 2022 Common Stock 25,000 $44.80 Direct F6
holding MMSI Non-qualified stock options (right to buy) 30,000 26 Feb 2022 Common Stock 30,000 $55.73 Direct F7
holding MMSI Non-qualified stock options (right to buy) 16,722 26 Feb 2022 Common Stock 16,722 $37.71 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020.
F2 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F3 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F4 Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
F5 Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F6 Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F7 Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F8 Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.